Stay updated on Elsubrutinib & Upadacitinib in SLE Clinical Trial
Sign up to get notified when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.

Latest updates to the Elsubrutinib & Upadacitinib in SLE Clinical Trial page
- ChecktodayChange DetectedThe record history now includes a new revision entry v3.7.0 and removes the earlier v3.6.6 entry, updating the version history.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision tag Revision: v3.6.6 was added to the history, replacing Revision: v3.6.5 and indicating an update to the record.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.6.5 now appears on the page, replacing v3.6.4 and signaling an updated site build for the Record History view.SummaryDifference0.1%

- Check50 days agoChange DetectedThe revision label on the study record history was updated from v3.6.3 to v3.6.4 to reflect a new site release.SummaryDifference0.1%

- Check71 days agoChange DetectedThe record history now shows a new revision tag v3.6.3, replacing the previous v3.6.2 in the current view. This indicates a minor metadata update to the page rather than changes to the trial data.SummaryDifference0.1%

- Check79 days agoChange DetectedThe record history now reflects a newer revision tag (v3.6.2) replacing the older v3.6.0, signaling a minor backend update to the page rather than a change to trial data. No substantive trial information is modified.SummaryDifference0.1%

Stay in the know with updates to Elsubrutinib & Upadacitinib in SLE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.